Statin use and ventricular arrhythmias during clinical treadmill testing

Journal of Cardiovascular Electrophysiology

Volumn 20, Issue 2, 2009, Pages 193-199

  Dewey, Frederick E ^a,d   Perez, Marco ^a   Hadley, David ^b   Freeman, James V ^a   Wang, Paul ^a   Ashley, Euan A ^a   Myers, Jonathan ^a,c   Froelicher, Victor F ^a,c  

^a STANFORD UNIVERSITY   (United States)

^b Cardiac Science   (United States)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^d NONE   (United States)

Author keywords

Exercise testing; Premature ventricular contractions; Risk; Statin

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; EXERCISE; FEMALE; HEALTH CARE SYSTEM; HEART BEAT; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HUMAN; HYPERCHOLESTEROLEMIA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREADMILL EXERCISE;

AGED; EXERCISE TEST; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; VENTRICULAR PREMATURE COMPLEXES;

EID: 59149084307     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2008.01284.x     Document Type: Article

References (35)

1. Frolkis JP, Pothier CE, Blackstone EH, Lauer MS : Frequent ventricular ectopy after exercise as a predictor of death. N Engl J Med 2003 348 : 781 790.
2. Jouven X, Zureik M, Desnos M, Courbon D, Ducimetiere P : Long-term outcome in asymptomatic men with exercise-induced premature ventricular depolarizations. N Engl J Med 2000 343 : 826 833.
3. Mora S, Redberg RF, Cui Y, Whiteman MK, Flaws JA, Sharrett AR, Blumenthal RS : Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: A 20-year follow-up of the lipid research clinics prevalence study. JAMA 2003 290 : 1600 1607.
4. Beckerman J, Mathur A, Stahr S, Myers J, Chun S, Froelicher V : Exercise-induced ventricular arrhythmias and cardiovascular death. Ann Noninvasive Electrocardiol 2005 10 : 47 52.
5. Dewey FE, Kapoor JR, Williams RS, Lipinski MJ, Ashley EA, Hadley D, Myers J, Froelicher VF : Ventricular arrhythmias during clinical treadmill testing and prognosis. Arch Intern Med 2008 168 : 225 234.
6. Fonarow GC, Wright RS, Spencer FA, Fredrick PD, Dong W, Every N, French WJ, for the National Registry of Myocardial Infarction 4 Investigators : Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality. Am J Cardiol 2005 96 : 611 616.
7. Chiu JH, Abdelhadi RH, Chung MK, Gurm HS, Marrouche NF, Saliba WI, Natale A, Martin DO : Effect of statin therapy on risk of ventricular arrhythmia among patients with coronary artery disease and an implantable cardioverter- defibrillator. Am J Cardiol 2005 95 : 490 491.
8. De Sutter J, Tavernier R, De Buyzere M, Jordaens L, De Backer G : Lipid lowering drugs and recurrences of life-threatening ventricular arrhythmias in high-risk patients. J Am Coll Cardiol 2000 36 : 766 772.
9. Mitchell LB, Powell JL, Gillis AM, Kehl V, Hallstrom AP AVID Investigators : Are lipid-lowering drugs also antiarrhythmic drugs? An analysis of the Antiarrhythmics versus Implantable Defibrillators (AVID) trial. J Am Coll Cardiol 2003 42 : 81 87.
10. Vyas AK, Guo H, Moss AJ, Olshansky B, McNitt SA, Hall WJ, Zareba W, Steinberg JS, Fischer A, Ruskin J, Andrews ML, for the MADIT-II Research Group : Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol 2006 47 : 769 773.
11. Kayikcioglu M, Can L, Evrengul H, Payzin S, Kultursay H : The effect of statin therapy on ventricular late potentials in acute myocardial infarction. Int J Cardiol 2003 90 : 63 72.
12. Dotani MI, Elnicki DM, Jain AC, Gibson CM : Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting. Am J Cardiol 2000 86 : 1128 1130.
13. Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, Crowe T, Howard G, Cooper CJ, Brodie B, Grines CL, DeMaria AN, for the REVERSAL Investigators : Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: A randomized controlled trial. JAMA 2004 271 : 1071 1080.
14. Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu EM, for the ASTEROID Investigators : Effect of very high-intensive statin therapy on regression of coronary atherosclerosis: The ASTEROID trial. JAMA 2006 295 : 1556 1565.
15. Pehlivanidis AN, Athyros VG, Demitriadis DS, Papageorgiou AA, Bouloukos VJ, Kontopoulos AG : Heart rate variability after long-term treatment with atorvastatin in hypercholesterolaemic patients with or without coronary artery disease. Atherosclerosis 2001 157 : 463 469.
16. Vrtovec B, Okrajsek R, Golicnik A, Ferjan M, Starc V, Radovancevic B : Atorvastatin therapy increases heart rate variability, decreases QT variability, and shortens QTc interval duration in patients with advanced chronic heart failure. J Card Fail 2005 11 : 684 690.
17. Pelat M, Dessy C, Massion P, Desager JP, Feron O, Balligand JL : Rosuvastatin decreases caveolin-1 and improves nitric oxide-dependent heart rate and blood pressure variability in apolipoprotein E-/-mice in vivo. Circulation 2003 107 : 2480 2486.
18. Pliquett RU, Cornish KG, Zucker IH : Statin therapy restores sympathovagal balance in experimental heart failure. J Appl Physiol 2003 95 : 700 704.
19. Mark L, Katona A : Effect of fluvastatin on QT dispersion: A new pleiotropic effect? Am J Cardiol 2000 85 : 919 920.
20. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, for the Modification of Diet in Renal Disease Study Group : A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 1999 130 : 461 470, 877 884.
21. Myers J, Do D, Herbert W, Ribisl P, Froelicher VF : A nomogram to predict exercise capacity from a specific activity questionnaire and clinical data. Am J Cardiol 1994 73 : 591 596.
22. Lachterman B, Lehmann KG, Abrahamson D, Froelicher VF : "Recovery only" ST-segment depression and the predictive accuracy of the exercise test. Ann Intern Med 1990 112 : 11 16.
23. Mark DB, Hlatky MA, Harrell FE Jr., Lee KL, Califf RM, Pryor DB : Exercise treadmill score for predicting prognosis in coronary artery disease. Ann Intern Med 1987 106 : 793 800.
24. Harrell FE Jr., Lee KL, Mark DB : Multivariable models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996 15 : 361 387.
25. Bazett HC : An analysis of the time-relations of electrocardiograms. Heart 1920 7 : 353 370.
26. Nair CK, Thomson W, Aronow WS, Pagano T, Ryschon K, Sketch MH : Prognostic significance of exercise-induced complex ventricular arrhythmias in coronary artery disease with normal and abnormal left ventricular ejection fraction. Am J Cardiol 1984 54 : 1136 1138.
27. Weiner DA, Levine SR, Klein MD, Ryan TJ : Ventricular arrhythmias during exercise testing: Mechanism, response to coronary bypass surgery, and prognostic significance. Am J Cardiol 1984 53 : 1553 1537.
28. McHenry PL, Morris SN, Kavalier M, Jordan JW : Comparative study of exercise-induced ventricular arrhythmias in normal subjects and patients with documented coronary artery disease. Am J Cardiol 1976 37 : 609 616.
29. Xing D, Murry DJ, Schmidt MS, Hohl RJ, Martins JB : Lovastatin specifically prevents focal ischemic ventricular tachycardia due to triggered activity. Heart Rhythm 2007 4 : 629 637.
30. Laufs U, La Fata V, Plutzky J, Liao JK : Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1998 97 : 1129 1135.
31. Hayashidani S, Tsutsui H, Shiomi T, Suematsu N, Kinugawa S, Ide T, Wen J, Takeshita A : Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation 2002 105 : 868 873.
32. Porter KE, Turner NA, O'Regan DJ, Balmforth AJ, Ball SG : Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA. Cardiovasc Res 2004 61 : 745 755.
33. Haigney MC, Zareba W, Gentlesk PJ, Goldstein RE, Illovsky M, McNitt S, Andrews ML, Moss AJ, for the Multicenter Automatic Defibrillator Implantation Trial II Investigators : QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. J Am Coll Cardiol 2004 44 : 1481 1487.
34. Berger RD : QT variability. J Electrocardiol 2003 36 : 83 87.
35. D'Agostino RB : Tutorial in biostatistics: Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998 17 : 2265 2281.